Sean Brynjelsen, President & CEO: Eton Pharmaceuticals ETON Sell · Filed 05/29

Trade details

Type: Insider sale
Amount: $4,835.16
Shares · price: 148 sh · $32.67 a share
Held after: 833,694 sh
Stock: Eton Pharmaceuticals ETON
Person: Sean BrynjelsenPresident & CEO
Trade date: 26/05/28
Filed: 26/05/29
Days to filing: 1 days

Sold under 0.1% of holdings

Share of holding sold: under 0.1%

Eton Pharmaceuticals trades, last 26 weeks

What else happened in Eton Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 04/28~06/27

Sean Brynjelsen's recent trades

Sean BrynjelsenPresident & CEO
Planned saleEton Pharmaceuticals
Planned sale
Eton Pharmaceuticals
ETON
$6.3M
100,000 sh
$6.3M
Filed 08/19
Traded 08/19
Sean BrynjelsenPresident & CEO
SellEton Pharmaceuticals
Sell
Eton Pharmaceuticals
ETON
$3.8M
119,852 sh
$3.8M
Filed 05/29
Traded 05/28
Sean BrynjelsenPresident & CEO
Planned saleEton Pharmaceuticals
Planned sale
Eton Pharmaceuticals
ETON
$3.9M
120,000 sh
$3.9M
Filed 05/28
Traded 05/28
Sean BrynjelsenPresident & CEO
Planned saleEton Pharmaceuticals
Planned sale
Eton Pharmaceuticals
ETON
$77.2K
5,015 sh
$77.2K
Filed 01/14
Traded 01/14
Sean BrynjelsenPresident & CEO
Planned saleEton Pharmaceuticals
Planned sale
Eton Pharmaceuticals
ETON
$135.6K
8,035 sh
$135.6K
Filed 25/12/12
Traded 25/12/12